Author:
Lansky Alexandra J.,Hochman Judith S.,Ward Patricia A.,Mintz Gary S.,Fabunmi Rosalind,Berger Peter B.,New Gishel,Grines Cindy L.,Pietras Cody G.,Kern Morton J.,Ferrell Margaret,Leon Martin B.,Mehran Roxana,White Christopher,Mieres Jennifer H.,Moses Jeffrey W.,Stone Gregg W.,Jacobs Alice K.
Abstract
More than 1.2 million percutaneous coronary interventions are performed annually in the United States, with only an estimated 33% performed in women, despite the established benefits of percutaneous coronary intervention and adjunctive pharmacotherapy in reducing fatal and nonfatal ischemic complications in acute myocardial infarction and high-risk acute coronary syndromes. This statement reviews sex-specific data on the safety and efficacy of contemporary interventional therapies in women.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
206 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献